{
  "content": "Purpose: Although the economic and mortality burden of atrial fibrillation (AF) is substantial, it remains unclear which treat-ment strategies for rate and rhythm control are most cost-effective. Consequently, economic factors can play an adjunctive role in guiding treatment selection.",
  "source": "https://pdfs.semanticscholar.org/798d/e6aa4ebeb8836fdffb27a98ab4195330069c.pdf",
  "chunk_id": "335f9679-04de-4783-8a0f-c3d383a28265",
  "similarity_score": 0.2724931240081787,
  "query": "cost effectiveness economic analysis amiodarone beta-blockers atrial fibrillation healthcare costs hospitalization reduction",
  "rank": 22,
  "title": "Cost-effectiveness of rate- and rhythm-control drugs for treating atrial fibrillation in Korea",
  "authors": "Min Kim, Woojin Kim, Changsoo Kim, Boyoung Joung",
  "year": "2019",
  "journal": "Yonsei Medical Journal",
  "reference": "Kim, M., Kim, W., Kim, C., & Joung, B. (2019). Cost-effectiveness of rate- and rhythm-control drugs for treating atrial fibrillation in Korea. Yonsei Medical Journal, 60(12), 1157-1163. https://doi.org/10.3349/ymj.2019.60.12.1157",
  "doi": "10.3349/ymj.2019.60.12.1157",
  "chunk_index": 3,
  "total_chunks": 62,
  "retrieved_at": "2025-07-24T21:58:16.915809"
}